Banco Bilbao Vizcaya Argentaria’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-35,201
| Closed | -$367K | – | 779 |
|
2023
Q4 | $367K | Buy |
35,201
+594
| +2% | +$6.19K | ﹤0.01% | 669 |
|
2023
Q3 | $355K | Sell |
34,607
-71,298
| -67% | -$731K | ﹤0.01% | 665 |
|
2023
Q2 | $799K | Buy |
105,905
+40,929
| +63% | +$309K | 0.01% | 560 |
|
2023
Q1 | $574K | Buy |
64,976
+43,156
| +198% | +$381K | 0.01% | 597 |
|
2022
Q4 | $197K | Sell |
21,820
-4,630
| -18% | -$41.9K | ﹤0.01% | 701 |
|
2022
Q3 | $215K | Sell |
26,450
-4,985
| -16% | -$40.5K | ﹤0.01% | 698 |
|
2022
Q2 | $241K | Sell |
31,435
-16,734
| -35% | -$128K | ﹤0.01% | 661 |
|
2022
Q1 | $452K | Sell |
48,169
-70,152
| -59% | -$658K | 0.01% | 604 |
|
2021
Q4 | $948K | Buy |
118,321
+77,842
| +192% | +$624K | 0.01% | 584 |
|
2021
Q3 | $396K | Sell |
40,479
-24,037
| -37% | -$235K | 0.01% | 658 |
|
2021
Q2 | $638K | Buy |
64,516
+3,006
| +5% | +$29.7K | 0.01% | 589 |
|
2021
Q1 | $708K | Sell |
61,510
-257,800
| -81% | -$2.97M | 0.01% | 547 |
|
2020
Q4 | $3.08M | Buy |
319,310
+121,221
| +61% | +$1.17M | 0.07% | 243 |
|
2020
Q3 | $1.78M | Sell |
198,089
-19,880
| -9% | -$179K | 0.05% | 286 |
|
2020
Q2 | $2.69M | Buy |
217,969
+21,283
| +11% | +$262K | 0.09% | 195 |
|
2020
Q1 | $1.77M | Sell |
196,686
-456,117
| -70% | -$4.1M | 0.06% | 282 |
|
2019
Q4 | $6.4M | Buy |
+652,803
| New | +$6.4M | 0.2% | 104 |
|